Why are patients with liver disease at increased risk for bleeding?

Choice A reason: Portal hypertension actually leads to sequestration of platelets in the spleen (splenomegaly), which causes thrombocytopenia, not hypercoagulability. Furthermore, increased blood flow to extremities is not a characteristic of portal hypertension; rather, blood is shunted into the collateral systemic circulation, often leading to esophageal varices. Choice B reason: The liver is the primary site for the synthesis of most coagulation factors, including fibrinogen, prothrombin, and factors V, VII, IX, and X. Hepatocellular damage severely impairs this biosynthetic function, leading to a profound deficiency in clotting proteins and a significantly increased risk for spontaneous hemorrhage. Choice C reason: Liver disease does not typically cause hypercalcemia that reduces clotting. In fact, calcium is a necessary cofactor for the clotting cascade (Factor IV). If anything, patients with liver disease may have low calcium levels, but the primary reason for bleeding remains the lack of protein-based clotting factors. Choice D reason: While bile production is necessary for the absorption of fat-soluble Vitamin K, which is a cofactor for certain clotting factors, the statement about platelet aggregation is incorrect. Reduced bile affects the synthesis of factors II, VII, IX, and X, but it does not directly impair the aggregation mechanism.